<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04574271</url>
  </required_header>
  <id_info>
    <org_study_id>PI 19-1425</org_study_id>
    <nct_id>NCT04574271</nct_id>
  </id_info>
  <brief_title>Multidimensional Intervention in Pre-frail Patients Older Than 70 Years</brief_title>
  <official_title>Multidimensional Intervention Directed to Pre-frail Patients Older Than 70 Years From Primary Care in a Basic Semi-urban Health Area</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Endocrinology and Clinical Nutrition Research Center, Spain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Endocrinology and Clinical Nutrition Research Center, Spain</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aging represents a huge advance in society and a health and social challenge. Spain has one&#xD;
      of the highest life expectancies in the world, but other countries with the same demographic&#xD;
      characteristics are ahead of us in quality adjusted life years. Primary care setting has the&#xD;
      main drivers of healthy aging, acting on the early stages of pre-frailty and frailty.&#xD;
&#xD;
      Therefore, it is proposed a multicomponent intervention (nutritional and prescription of&#xD;
      physical exercise) in patients older than 70 years of the Medina del Campo Health Center,&#xD;
      with pre-frailty criteria, in order to measure the changes that this intervention produces in&#xD;
      their mild dysfunction and whether it is capable of reversing it or delaying the progression&#xD;
      to a state of frailty.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypothesis: A balanced diet, with a sufficient protein intake for each patient based on the&#xD;
      Mediterranean diet, as well as the performance of multicomponent exercise 3 times a week,&#xD;
      delays the evolution to stages of dysfunction or disability in the pre-frail population.&#xD;
&#xD;
      Objective:&#xD;
&#xD;
        -  The main objective is to evaluate the effect of an intensive nutritional dietary&#xD;
           treatment on the function markers in a sample of elderly people in a situation of&#xD;
           pre-frailty.&#xD;
&#xD;
        -  To Demonstrate the equivalence of the values obtained in terms of functional improvement&#xD;
           through adequate exercise and diet in urban populations in a semi-urban population.&#xD;
&#xD;
        -  To evaluate the change in analytical markers that indicate pre-frailty in patients under&#xD;
           intensive dietary-nutritional treatment.&#xD;
&#xD;
        -  To Study the improvement of quality of life in individuals with adequate nutrition and&#xD;
           level of physical exercise in those over 70 years of age in pre-frailty stages,&#xD;
           increasing the prevalence of healthy aging in our study population.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      - Design: This is a quasi-experimental study with a control group. Recruitment will be&#xD;
      carried out, through random sampling, of patients over 70 years of age from the basic health&#xD;
      area of Medina del Campo Urbano, detecting those who meet Fried's pre-frailty criteria,&#xD;
      through the FRAIL questionnaire, being positive for pre-frailty fulfilling 1 or 2 criteria.&#xD;
      These subjects detected as pre-frail will be randomly included in different multicomponent&#xD;
      programs. In a group, two types of interventions will be carried out by the research team&#xD;
      from primary care: Dietary advice adjusted to the needs of the patient and their pre-frailty&#xD;
      stage, with an adequate nutritional and protein intake, based on the scientific evidence&#xD;
      existing to date and in collaboration with the Clinical Hospital of Valladolid, Spain; and a&#xD;
      multicomponent physical exercise prescription (elasticity, strength, resistance and balance),&#xD;
      of at least 150 minutes per week, according to the WHO recommendations for this age group,&#xD;
      adapting it individually, to be performed 3-5 times per week. Both branches of the&#xD;
      intervention will be carried out through periodic interviews throughout a year of follow-up.&#xD;
&#xD;
      In the control group, the nutritional advice and prescription of regular physical exercise&#xD;
      will be developed by the health team of the primary care center.&#xD;
&#xD;
      During this year, the parameters to be measured of functionality and independence, as well as&#xD;
      anthropometric, quality of life and corresponding analytical parameters will be evaluated&#xD;
      prior to the beginning of the intervention. Evaluating their variation at 3 months, 6 months&#xD;
      and one year in both groups.&#xD;
&#xD;
        -  Sample Size: It has been calculated to estimate a proportion similar to that of the&#xD;
           population. Based on the prevalence of 50% existing in other study samples in the&#xD;
           national territory for pre-frailty, and thus choosing the position of maximum&#xD;
           indeterminacy (p = 50), assuming normality, for an Î± = 0.05 the Measure of the resulting&#xD;
           sample calculated was 338 individuals.&#xD;
&#xD;
        -  Chronogram:&#xD;
&#xD;
      Selection of patients: june 2019. Phone recruiting of patients: june 2019 Clinical and&#xD;
      functional assessment will be carried out in Medina del Campo Health Center and&#xD;
      randomization: july 2019-August 2019.&#xD;
&#xD;
      Intervention (First Time): October-december 2019; january-february 2020; july-august 2020;&#xD;
      september-october 2020.&#xD;
&#xD;
      Follow up: Evaluation of parameters. July-August 2020; september-october 2020;&#xD;
      november-december 2020; january-february 2021.&#xD;
&#xD;
      Statistycal Analysis: March-April 2021 Drafting of results: May-June 2021&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Intervention Group: Intensitve nutritional advice and exercise prescription adapted to physical performance.&#xD;
Control Group: Usual nutritional advice and exercise prescription.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional assessment by Fried Criteria</measure>
    <time_frame>12 months</time_frame>
    <description>Test of frail syndrome diagnosis in elder patients (Three out five criteria)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fall Risk by test up and go</measure>
    <time_frame>12 months</time_frame>
    <description>Functional tests of frail syndrome diagnosis in elder patients (&lt;10 seconds: low fall risk; 10-20 seconds: fragility (risk of fall); &gt;20 seconds: high risk of fall).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The Lawton Instrumental Activities of Daily Living (IADL) Scale</measure>
    <time_frame>12 months</time_frame>
    <description>Functional tests of frail syndrome diagnosis in elder patients (Grade of depedence: &lt;20: Total; 20-35: Severe; 40-55: Moderate; &gt;60: Mild; 100: Independent).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Barthel Test for dependency</measure>
    <time_frame>12 months</time_frame>
    <description>Functional tests of frail syndrome diagnosis in elder patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mini-Mental Test</measure>
    <time_frame>12 months</time_frame>
    <description>Cognitive evaluation (0-14: severe cognitive impairment; 15-19: moderate cognitive impairment; 20-24 mild cognitive impairment; 25-30: soft deficit of cognitive function; 30-35: normal).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short Form 36 (SF-36) Health survey Questionnaire</measure>
    <time_frame>12 months</time_frame>
    <description>Questionnaire to measure quality of life (0-100 --&gt; 0=worst health status - 100=better health status).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">340</enrollment>
  <condition>Frail Elderly Syndrome</condition>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>Intensive dietary advice and exercise prescription</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Personalized dietary advice and exercise prescription according to nutritional status.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual dietary advice and exercise prescription</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Generalized dietary advice and exercise prescription in elder subjects.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Intensive dietary advice and exercise prescription</intervention_name>
    <description>Personalized dietary advice and exercise prescription according to nutritional status.</description>
    <arm_group_label>Intensive dietary advice and exercise prescription</arm_group_label>
    <other_name>Personalized dietary advice and exercise prescription</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Usual dietary advice and exercise prescription</intervention_name>
    <description>Generalized dietary advice and excercise prescription in elder patients.</description>
    <arm_group_label>Usual dietary advice and exercise prescription</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Non-institutionalized patients over 70 years of age from the basic health area of&#xD;
             Medina del Campo Urbano, who meet pre-frailty criteria (1 or 2 Fried criteria).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cognitive impairment&#xD;
&#xD;
          -  Frailty syndrome&#xD;
&#xD;
          -  Moderate-Severe Dependence&#xD;
&#xD;
          -  Life Expectancy less than 6 months or patients in palliative care&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juan J LOPEZ-GOMEZ, MD; PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital ClÃ­nico Universitario de Valladolid</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel A De Luis RomÃ¡n, MD; PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Valladolid</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cristina GutiÃ©rrez-Lora, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Primary Care Center (Medina del Campo (Valladolid, Spain))</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juan J LOPEZ-GOMEZ, MD; PhD</last_name>
    <phone>983420000</phone>
    <phone_ext>86158</phone_ext>
    <email>jjlopez161282@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniel A. De Luis RomÃ¡n, MD; PhD</last_name>
    <phone>983420000</phone>
    <phone_ext>86660</phone_ext>
    <email>dadluis@yahoo.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cristina GutiÃ©rrez-Lora</name>
      <address>
        <city>Medina del Campo</city>
        <state>Valladolid</state>
        <zip>47400</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina GutiÃ©rrez-Lora, MD</last_name>
      <phone>983812750</phone>
      <email>cgulora@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Cristina GutiÃ©rrez-Lora, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Daniel A De Luis-Roman, MD; PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan J LÃ³pez-Gomez, MD; PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristina GutiÃ©rrez-Lora, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pilar Nieto GonzÃ¡lez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nuria Gracia RodrÃ­guez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Almudena Casas Manzanas</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miguel A GarcÃ­a RodrÃ­guez, MD; PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ismael Calcerrada Alises</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Javier Gamarra Ortiz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>MarÃ­a San MillÃ¡n-GonzÃ¡lez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 27, 2020</study_first_submitted>
  <study_first_submitted_qc>October 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2020</study_first_posted>
  <last_update_submitted>October 1, 2020</last_update_submitted>
  <last_update_submitted_qc>October 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Endocrinology and Clinical Nutrition Research Center, Spain</investigator_affiliation>
    <investigator_full_name>Daniel de Luis Roman</investigator_full_name>
    <investigator_title>Professor, MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

